Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$10,120 Mln
Revenue (TTM)
$958 Mln
Net Profit (TTM)
$0 Mln
ROE
-0.4 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
16.8
Industry P/E
--
EV/EBITDA
-8.3
Div. Yield
0 %
Debt to Equity
0.6
Book Value
$26.9
EPS
$-12.9
Face value
--
Shares outstanding
22,939,969
CFO
$-1,147.99 Mln
EBITDA
$-1,462.51 Mln
Net Profit
$-1,429.46 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Madrigal Pharmaceuticals (MDGL)
| -12.3 | 14.5 | -14.7 | 53.0 | 29.6 | 34.4 | 50.9 |
|
BSE Sensex
| -13.1 | -10.5 | -13.5 | -4.8 | 8.6 | 8.5 | 11.3 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Madrigal Pharmaceuticals (MDGL)
| 88.7 | 33.0 | -20.3 | 242.5 | -23.8 | 22.0 | -19.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Madrigal Pharmaceuticals (MDGL)
|
510.7 | 10,120.2 | 958.4 | -288.3 | -27.8 | -42.5 | -- | 16.8 |
| 57.8 | 7,888.0 | 1,091.0 | 202.3 | 31.6 | 31.3 | 35.2 | 13.9 | |
| 217.0 | 13,621.9 | 691.7 | -219.0 | -13.7 | 163.2 | -- | 14.6 | |
| 62.5 | 7,599.2 | 88.0 | -785.0 | -808.1 | 197.5 | -- | 60.3 | |
| 41.5 | 11,065.0 | 2,320.1 | 782.6 | 39.0 | 35.5 | 14.8 | 5.0 | |
| 84.6 | 11,173.1 | 982.0 | -416.3 | -42.1 | 348.4 | -- | 55.7 | |
| 61.6 | 7,485.8 | 1,396.6 | 316.9 | 59.8 | 153.6 | 24.7 | 153.4 | |
| 7.4 | 8,708.1 | 113.3 | -351.4 | -211.0 | 71.1 | -- | 0.0 | |
| 451.2 | 12,842.8 | 2,530.2 | 451.1 | 21.3 | 70.2 | 29.6 | 28.5 | |
| 290.1 | 8,308.2 | 0.0 | -303.3 | -- | -45.8 | -- | 9.5 |
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor... beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania. Read more
Founder, Chief Medical Officer, President of Research & Development and Director
Dr. Rebecca A. Taub M.D.
Founder, Chief Medical Officer, President of Research & Development and Director
Dr. Rebecca A. Taub M.D.
Headquarters
West Conshohocken, PA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Madrigal Pharmaceuticals Inc (MDGL) is $510.68 (NASDAQ) as of 27-Mar-2026 16:20 EDT. Madrigal Pharmaceuticals Inc (MDGL) has given a return of 29.59% in the last 3 years.
Since, TTM earnings of Madrigal Pharmaceuticals Inc (MDGL) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-45.32
|
21.68
|
|
2024
|
-14.52
|
8.97
|
|
2023
|
-12.24
|
11.28
|
|
2022
|
-16.94
|
25.35
|
|
2021
|
-6.00
|
7.38
|
The 52-week high and low of Madrigal Pharmaceuticals Inc (MDGL) are Rs 615.00 and Rs 265.00 as of 28-Mar-2026.
Madrigal Pharmaceuticals Inc (MDGL) has a market capitalisation of $ 10,120 Mln as on 20-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Madrigal Pharmaceuticals Inc (MDGL), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$-8.08
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.